Contract Manufacturing, Cosmetics and Trials

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Contract Manufacturing

Cosmetics

Trials

FDA $7bn plans for 2024: disclose contract manufacturers, restart Cancer Moonshot

Pharmaceutical Technology

MARCH 30, 2023

The US FDA has revealed its detailed budget proposal for FY2024, which would require pharma companies to name their active pharmaceutical ingredient (API) suppliers, restart President Biden’s Cancer Moonshot, inject cash into amyotrophic lateral sclerosis (ALS) research, and enforce stricter rules around manufacturing, recalls, and shortages.

Contract Manufacturing

Contract Manufacturing Manufacturing Pharma Companies Cosmetics

FDA End-of-Year Release of Warning Letters Impresses (or Depresses)

FDA Law Blog

JANUARY 1, 2024

Perhaps FDA wanted us to remember 2023 as the year FDA succeeded in uncovering critical defects in drug and device manufacturing, and in critical trials. Patcos Cosmetics Pvt. If FDA wanted to create that impression, it likely succeeded. They have great impact on most companies that receive them. Dextrum Laboratories Inc.

Manufacturing

Manufacturing Production Drugs FDA Compliance

Clinical Research Informer

FDA $7bn plans for 2024: disclose contract manufacturers, restart Cancer Moonshot

FDA End-of-Year Release of Warning Letters Impresses (or Depresses)

Stay Connected